[EIP 2015] Meningitis Update – Latest Recommendations and Guidelines for the Meningitis Booster for Adolescents

Recorded: EIP 2015 ● Language: English ● Duration: 22 minutes Topic: Adolescent Medicine

     
 

Speaker: GEORGE A. SYROGIANNOPOULOS, Professor and Chairman of Paediatrics at the University of Thessaly, School of Medicine in Larissa, Greece

 
     
  Learning Objectives: At the end of the Session participants will: (1) learn that the highest incidence of meningococcal disease occurs in children under 5 years of age, but a second peak occurs in adolescents and higher case fatality rates are generally reported in this age group; (2) understand that children are being immunized in infancy with the meningococcal serogroup C conjugate vaccine; (3) learn that as children get older the protective antibody titres against meningococcal serogroup C are waning; and (4) adolescents need to receive a booster dose and currently a quadrivalent meningococcal conjugate vaccine (MenACYW), offering coverage against serogroup C, as well against serogroups A, Y and W135, is recommended  
         

 




Click on a tag to view other related posts

get updates

connect